tirzepatide surpass-5 Media Centre SURMOUNT-5: Tirzepatide and semaglutide go
Description
12 mg: -1.7% [0.19]
This flexibility allows healthcare providers to tailor the therapy to individual patient needs
Statistical analysis will be conducted using software such as SPSS (V29.0) and R (V4.4.0)
Improving metabolic function for sustained weight loss
